WebGenocea Biosciences (NASDAQ:GNCA) is closing down its business. It’s terminating all employees not needed to shut the company down. This also has it delisting shares of … WebThe Market Watch features real-time quotes of financial instruments and other price data: spread, volume, etc. The displayed data can be configured in the context menu. For example, you can show the "Source" field — the provider of the financial instrument liquidity. Double-clicking on one of the instruments opens a new position opening window.
GNCA (GNCA) Stock Price, Quote, News & History Nasdaq
Web30 mrt. 2024 · Chip Clark. Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that … WebGNCA Stock Quote Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield 1 day 5 days 10 days 1 … small bodied fish
Monopar Therapeutics Inc. - MarketWatch
WebYou can watch GNCA and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling, read news, … Web15 nov. 2024 · GNCA Complete Genocea Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Skip to main … GNCA Profile Stock Screener Earnings Calendar Sectors GNCA U.S.: OTC … GNCA Genocea Biosciences Inc. SEC Filings MarketWatch Genocea … Web15 jun. 2024 · Genocea Biosciences Inc (OTCMKTS: GNCA) is a biopharmaceutical company dedicated to discovering and developing novel cancer immunotherapies using our proprietary ATLASTM platform. The ATLAS platform can profile each patient’s CD4+ and CD8+ T cell immune responses to every potential target or “antigen” identified by next … small bodied acoustic